Bruker AXS Wins Prestigious R&D 100 Award For Innovative VANTEC(TM)-2000 X-ray Detector Used in Materials Science ResearchBruker

Bruker AXS Inc., a leading global provider of advanced
X-ray solutions for life and advanced materials sciences, announced
today that R&D Magazine has selected its VANTEC-2000 detector for a
2005 R&D 100 Award, which recognizes the most technologically
significant products introduced into the marketplace during the past
year.
   "Since its introduction, the VANTEC-2000 has dramatically boosted
the performance of X-ray diffraction (XRD) detectors for materials
research. It combines low noise, high sensitivity, excellent spatial
resolution and dynamic range with real-time data acquisition. This
even allows for snapshot and movie mode acquisition in a virtually
maintenance-free detector, that is unrivalled in the XRD marketplace,"
stated Uwe Preckwinkel, the Bruker AXS U.S. XRD Product Manager.
   Unlike older XRD detector technologies, the VANTEC-2000 measures
the two-dimensional X-ray diffraction pattern from a sample. The
result allows for the calculation of a wide variety of physical
parameters in a broad range of sample types. Because of its unique
capability to detect individual photons at up to 2 million counts per
second, the detector is ideal for the analysis of weakly and/or
strongly scattering samples - including smallest sample traces, single
crystals, epitaxial thin films, coatings, rocks, polymers, metals,
steel, wood, plastics, liquids, nanomaterials and more.
   The award, selected by an independent panel of judges and the
editors of R&D Magazine, "provides a mark of excellence known to
industry, government, and academia as proof that the product is one of
the most innovative ideas of the year," explained the magazine's
Editor-in-Chief, Tim Studt.

   About Bruker Biosciences (NASDAQ: BRKR)

   Bruker BioSciences Corporation, headquartered in Billerica,
Massachusetts, is the publicly traded parent company of Bruker AXS
Inc. and Bruker Daltonics Inc. Bruker AXS is a leading worldwide
developer and provider of advanced X-ray systems which provide
solutions for molecular and elemental analysis by X-ray
crystallography, X-ray diffraction and X-ray fluorescence. Its
systems, which have particular application in the life science,
materials science and nanotechnology research fields, provide
customers with high-throughput capabilities to determine small
molecule and protein structures, or to characterize and determine the
composition and properties of advanced and nano-materials. For more
information, please visit www.bruker-axs.com.

   Cautionary Statement

   Any statements contained in this press release with respect to
Bruker AXS or Bruker BioSciences or their businesses that do not
describe historical facts may constitute forward-looking statements as
that term is defined in the Private Securities Litigation Reform Act
of 1995. Any forward-looking statements contained herein are based on
current expectations, but are subject to a number of risks and
uncertainties. The factors that could cause actual future results to
differ materially from current expectations include, but are not
limited to, risks and uncertainties relating to the Company's
reorganization strategies, integration risks, failure of conditions,
technological approaches, product development, market acceptance, cost
and pricing of the Company's products, changes in governmental
regulations, capital spending and government funding policies, FDA and
other regulatory approvals to the extent applicable, competition, the
intellectual property of others, patent protection and litigation.
These and other factors are identified and described in more detail in
our filings with the SEC, including, without limitation, our
respective annual reports on Form 10-K for the year ended December 31,
2004, our most recent quarterly reports on Form 10-Q, our current
reports on Form 8-K and the joint proxy statement/prospectus filed in
connection with the merger. We disclaim any intent or obligation to
update these forward-looking statements.